3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
128
Brain Neoplasms
114
Prostatic Neoplasms
101
Neoplasm Metastasis
83
Lung Neoplasms
71
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
67
Breast Neoplasms
47
Melanoma
44
Carcinoma, Renal Cell
36
Neoplasms
33
Colorectal Neoplasms
26
Squamous Cell Carcinoma of Head and Neck
25
Glioblastoma
24
Liver Neoplasms
20
Head and Neck Neoplasms
16
Small Cell Lung Carcinoma
15
Sarcoma
13
Glioma
12
Kidney Neoplasms
11
Urinary Bladder Neoplasms
9
Recurrence
9
Gliosarcoma
8
Ovarian Neoplasms
7
Adenocarcinoma of Lung
7
Adenocarcinoma
7
Prostate Cancer Metastatic
6
Cholangiocarcinoma
6
Central Nervous System Neoplasms
6
Uveal Melanoma
5
Interventions
pembrolizumab
4
Pemetrexed
4
Carboplatin
4
Gemcitabine
3
Bevacizumab
3
tusamitamab ravtansine
2
Vinorelbine
2
Ramucirumab
2
Erlotinib Hydrochloride
2
Docetaxel
2
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
2
vistusertib
1
vandetanib
1
telomerase reverse transcriptase p572Y, human
1
spartalizumab
1
sotorasib
1
sintilimab
1
olaparib
1
necitumumab
1
icotinib
1
durvalumab
1
dacomitinib
1
capivasertib
1
aumolertinib
1
Radiosurgery
1
Platinum
1
Paclitaxel
1
MLN 8237
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Non-small Cell Lung Cancer Metastatic
×
Radiosurgery
×
Clear all
NCT06127940
2023-11-13
K-SAB
Karolinska University Hospital
Phase 1
Unknown
20 enrolled